Helicobacter Pylori Testing Market Analysis And Forecast To 2031: By Test (Invasive, Non-Invasive), By Method (Point-of-Care (POC) Test, Laboratory Based Test), By End-use (Hospitals, Clinics, Diagnostic Laboratories), And Region

Helicobacter Pylori Testing Market Analysis And Forecast To 2031: By Test (Invasive, Non-Invasive), By Method (Point-of-Care (POC) Test, Laboratory Based Test), By End-use (Hospitals, Clinics, Diagnostic Laboratories), And Region

The global Helicobacter Pylori Testing Market was valued at USD 436.0 Million in 2021 and it is anticipated to grow up to USD 915.4 Million by 2031, at a CAGR of 7.7% during the forecast period.

Helicobacter pylori testing is a way to determine if a person has an infection with the bacteria Helicobacter pylori. This bacteria is known to cause stomach ulcers, and testing can help to diagnose an infection and determine the best course of treatment. There are a few different ways to test for H. pylori, including a stool sample, a breath test, or a biopsy.
Global Helicobacter Pylori Testing Market Scope and Report Structure

Market Trends and Drivers
The most important driver of the H. pylori testing market is the high prevalence of H. pylori infection. It is estimated that H. pylori infects more than half of the world’s population. The prevalence is highest in developing countries and lowest in developed countries. The second important driver of the H. pylori testing market is the increasing awareness of the link between H. pylori infection and gastric cancer. Gastric cancer is the fourth most common cancer in the world and the second leading cause of cancer death. H. pylori infection is a major risk factor for gastric cancer. The third important driver of the H. pylori testing market is the increasing incidence of ulcers. Ulcers are a common condition and their incidence is increasing due to the increasing prevalence of H. pylori infection. The fourth important driver of the H. pylori testing market is the increasing demand for rapid and accurate testing methods. The currently available methods for H. pylori testing are culture, histology, urea breath test, and stool antigen test. However, these methods are time-consuming and expensive. The fifth important driver of the H. pylori testing market is the development of new and improved testing methods. Newer methods, such as PCR and ELISA, are more rapid and accurate than the older methods.
Market Restraints and Challenges
Helicobacter pylori infection is typically diagnosed through an invasive procedure, which entails biopsy and endoscopy, and requires advanced operational skills for precisely diagnosing and identifying the appropriate treatment method. However, the lack of trained professionals in nations with limited healthcare resources may affect the disease testing rates, dampening the market progress. Many low and middle-income economies lack the hospital and medical training infrastructure needed to highly skilled physicians. Helicobacter pylori treatment also poses other challenges for physicians as no first-line therapy can treat the infection for all patients.
Global Helicobacter Pylori Testing Market Segmental Overview
The report analyses the global Helicobacter Pylori Testing Market based on test type, method, end-user, and region.

Global Helicobacter Pylori Testing Market by Test Type

Based on test type, the market is segregated as Invasive, and Non-invasive. Amongst them, invasive helicobacter test segment is poised to register a significant CAGR from 2023 to 2031, driven by the efficacy and cost-effectiveness of rapid urease tests. The demand for invasive testing method is also high among patients do not correspond well to antibiotic therapy, have symptoms of severe gastric problems, and further require gastric endoscopy.

Global Helicobacter Pylori Testing Market by Method

On the basis of the method, the helicobacter pylori testing market is categorized into laboratory-based tests and point-of-care (POC) tests. The POC tests segment accounted for a significant business share in 2022, due to its non-invasive nature and its ability to deliver fast results. This is also attributed to collaborative research initiatives by leading industry giants and increasing R&D spending, which is further encouraging technological advancements as well as new product launches.

Global Helicobacter Pylori Testing Market by End-user

With regards to end-user, the Helicobacter Pylori Testing Market is divided into Hospital & Clinics, Diagnostic labs, and others. Hospital & Clinics generated considerable revenue in 2021 and is expected to grow at a highest CAGR over the analysis period. This is owing to the rising patient preference for clinics due to affordability and quality care. This is driven by the high-quality treatment and quick assistance offered by clinics, which provides the desired treatment results at a reasonable cost. In addition, the high-end services offered by clinics through effective disease management strategies are further set to spur segment expansion.
Geographical Analysis of Global Helicobacter Pylori Testing Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America Helicobacter Pylori Testing Market revenue is poised to grow significant CAGR during the forthcoming years. This can be attributed to the presence of industry leaders, as well as an emphasis on continual technological developments and new product releases, has contributed to the regional market's growth. Revenue growth is slated to be fueled by the rising occurrences of infectious ailments and increasing aging population in the region. Poor healthcare infrastructure and low awareness about good sanitary practices across developing APAC economies is further projected to fuel the demand for helicobacter pylori tests.
Major Players in the Global Helicobacter Pylori Testing Market
The key players in the Helicobacter Pylori Testing Market Abbott Laboratories, Avanos Corporate, Biohit Oyj, Bio-Rad Laboratories, Inc., Cardinal Health, Exalenz Bioscience Ltd., Gulf Coast Scientific, Medline Industries, Inc. , Thermo Fisher Scientific Inc. and QIAGEN. among others.
COVID-19 Impact
In the initial months of 2020, COVID-19 made a severe negative impact on the h. pylori testing industry. Many h. pylori patients avoided hospital visits on account of the rapidly increasing COVID-19 cases and mortality rates, which overwhelmed healthcare facilities and spread infection fears among the global population. Additionally, the infection risks associated with invasive helicobacter pylori testing at point-of-care treatment units also led to disruption in the sector. Since the route of virus transmission is nasal or oral, the non-invasive tests such as the urea breath tests (UBT) were also impacted as they held a high possibility of COVID-19 transmission. Now, as successful vaccination drives turn COVID-19 into an afterthought, the market is expected to bounce back in a notable manner.
Recent Developments

In June 2022, Phathom Pharmaceuticals announced that FDA approved Voquenza (vonoprazan fumarate), in combination with anti-biotics, for H.pylori infection.
In September 2021, Phathom Pharmaceuticals Submited two NDAs to U.S. FDA for Vonoprazan-based treatment regimens for the treatment of H. pylori infection.
In July 2021, Meridian Signs Definitive Agreement to Acquire Urea Breath Test for H. pylori from Otsuka America Pharmaceutical, Inc.
In March 2020, RedHill Biopharma Ltd., announced the U.S. commercial launch of Talicia® 1 delayed-release capsules 10 mg2/250 mg/12.5 mg for the treatment of Helicobacter pylori (H. pylori) infection in adults. RedHills expanded U.S. sales force will promote Talicia® nationwide to approximately 25,000 gastroenterologists, primary care physicians and other healthcare providers.

Frequently Asked Questions
Q1. How big is the Helicobacter Pylori Testing Market ?

Ans. The global Helicobacter Pylori Testing Market was valued at USD 436.0 Million in 2021 and it is anticipated to grow up to USD 915.4 Million by 2031, at a CAGR of 7.7% during the forecast period.

Q2. What is the Helicobacter Pylori Testing Market growth rate?

Ans. The growth rate of the Helicobacter Pylori Testing Market is 17.1%.

Q3. Which region holds a major market share for the market?

Ans. North America holds a major market share of the Helicobacter Pylori Testing Market in 2021.

Q4. Which segment accounted for the largest Helicobacter Pylori Testing Market share?

Ans. By end user, the hospital& clinics segment accounted for the largest Helicobacter Pylori Testing Market share.

Q5. Who are the key players in the digital diabetes management market?

Ans. The global Helicobacter Pylori Testing Market report includes players such as  Abbott Laboratories, Avanos Corporate, Biohit Oyj, Bio-Rad Laboratories, Inc., Cardinal Health, Exalenz Bioscience Ltd., Gulf Coast Scientific, Medline Industries, Inc. , Thermo Fisher Scientific Inc. and QIAGEN, among others.

Q6. What are the factors driving the Helicobacter Pylori Testing Market growth?

Ans. The major factors driving the growth of the market are growing prevalence of H, pylori across the globe.

Q7. What are the key growth strategies of Helicobacter Pylori Testing Market players?

Ans. The key growth strategies of Helicobacter Pylori Testing Market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the Helicobacter Pylori Testing Market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the Helicobacter Pylori Testing Market during the forecast period.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.